Announced Thu, 25 Jun · 12:28 IST
Mankind Pharma: Trading window closed from July 1 ahead of Q1 results
Compliance View source PDF
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹2472.70
prior close
₹2483.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.0-0.2-0.2+0.4+3.1+0.5+0.3+2.3+2.0+0.3+2.8——
Up moveDown movePending
AI summary
Mankind Pharma has closed the trading window for designated persons and their immediate relatives from July 1, 2026 until 48 hours after the board declares unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The board meeting date for Q1 FY27 results will be announced later. This is a routine SEBI insider trading compliance measure taken ahead of the upcoming earnings announcement.
Likely market impact
Routine compliance filing signalling upcoming Q1 FY27 results. No direct impact on shareholders, but results are expected in the coming weeks.